A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: In vitro and in vivo evaluation

Pharmaceutical Research

Volumn 27, Issue 1, 2010, Pages 105-114

  Guan, Jin ^a   Zhou, Liying ^a   Pan, Yusheng ^a   Han, Haitao ^a   Xu, Hongtao ^a   Pan, Weisan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Asymmetric membrane; Central composite design; Famotidine; Gastro retentive osmotic pump capsule; Pharmacokinetic study

Indexed keywords

FAMOTIDINE; GLYCEROL; MACROGOL; PHTHALIC ACID DIETHYL ESTER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; EXPERIMENTAL DOG; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MEMBRANE STRUCTURE; MEMBRANE TECHNOLOGY; MOLECULAR WEIGHT; NONHUMAN; OSMOTIC PUMP; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TABLET FORMULATION; THICKNESS; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; CAPSULES; DELAYED-ACTION PREPARATIONS; DOGS; DRUG CARRIERS; DRUG COMPOUNDING; FAMOTIDINE; GASTRIC EMPTYING; MALE; MEMBRANES, ARTIFICIAL; OSMOTIC PRESSURE; SOLUBILITY;

EID: 72949088835     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9984-1     Document Type: Article

References (23)

1. LX Liu XN Xu 2007 Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet Int J Pharm. 10 1 6 10.1016/j.ijpharm.2007.05. 049 (Pubitemid 47088122)
2. LX Liu G Khang JM Rhee HB Lee 2000 Monolithic osmotic tablet system for nifedipine delivery J Controlled Release. 67 309 22 10.1016/S0168-3659(00)00222- 4 1:CAS:528:DC%2BD3cXjsVegtrY%3D (Pubitemid 30303844)
3. HR Chueh H Zia CT Rhodes 1995 Optimization of sotalol floating and bioadhesive extended release tablet formulations Drug Dev Ind Pharm. 21 1725 47 10.3109/03639049509069261 1:CAS:528:DyaK2MXmvFWlu7o%3D
4. V Iannuccelli G Coppi MT Bernabei R Cameroni 1998 Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study Int J Pharm. 174 47 54 10.1016/S0378-5173(98)00229-4 1:CAS:528: DyaK1cXmsFGntb8%3D (Pubitemid 28486988)
5. S Desai S Bolton 1993 A floating controlled-release drug delivery systems: in vitro-in vivo evaluation Pharm Res. 10 1321 5 10.1023/A: 1018921830385 1:CAS:528:DyaK3sXmtleqsLc%3D 8234170 (Pubitemid 23261833)
6. AG Thombre JR Cardinal, et al. 1999 Asymmetric membrane capsules for osmotic drug delivery I. Development of a manufacturing process J Control Release. 57 55 64 10.1016/S0168-3659(98)00100-X 1:CAS:528:DyaK1cXotVymtLs%3D 9863039 (Pubitemid 29005073)
7. CY Wang HO Ho LH Lin, et al. 2005 Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects Int J Pharm. 297 89 97 1:CAS:528:DC%2BD2MXkt1ansLc%3D 15885936
8. RW McCallum AN Chremos B Kuljian, et al. 1985 A novel histamine H2-receptor inhibitor with prolonged antisecretory effect Dig Dis Sci. 30 1139 10.1007/BF01314047 1:CAS:528:DyaL28XotFyhtg%3D%3D 2866073
9. AG Thombre JR Cardinal, et al. 1999 Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance J Control Release. 57 65 73 10.1016/S0168-3659(98)00101-1 1:CAS:528: DyaK1cXotVymtLg%3D 9863040 (Pubitemid 29005074)
10. LC Gan SX Hou YQ Bi, et al. 2007 Optimized preparation of tanshinones || A-loaded nanoparticles by central composite design and response surface method Chi Pharm J. 42 758 61 1:CAS:528:DC%2BD1cXntFCgsbo%3D
11. K.M. Wagner. Like dissolves like. The 19th Biennial Conference on Chemical Education, West Lafayette; 2006.
12. HF Frasch AM Barbero 2005 Application of solid-phase microextraction to in vitro skin permeation experiments: example using diethyl phthalate Toxicology in Vitro. 19 253 9 10.1016/j.tiv.2004.10.001 1:CAS:528:DC%2BD2MXksVChtg%3D%3D 15649639 (Pubitemid 40092748)
13. JH Liu L Ye HS Liu 1995 Flow patterns of flow boiling of a highly viscous pseudoplastic fluid Int C Heat Mass Transfer. 22 359 67 10.1016/0735-1933(95) 00027-V 1:CAS:528:DyaK2MXmvFKls7w%3D
14. Cui FD. Pharmaceutics. 1st ed. Beijing: China Press of Chinese Medicine Technology; 2002.
15. Su DS, Wang SL. Physical Pharmaceutics. 1st ed. Beijing: Chemical Industry; 2004.
16. Buckman HO, Brady NC. The nature and property of soils-A college text of edaphology. 6th ed. New York: MacMillan; 1960.
17. XP Cao N Leyvaa SR Andersona BC Hancocka 2008 Use of prediction methods to estimate true density of active pharmaceutical ingredients Int J Pharm. 355 231 7 10.1016/j.ijpharm.2007.12.012 1:CAS:528:DC%2BD1cXkt1ygsrY%3D 18242023
18. POLYOX Water-Soluble Resins Dissolving Techniques. The Dow Chemical Company, Form No. 326-00002-0303 AMS; 2003.
19. E Broda 1938 Limited and unlimited swelling of high molecular substances Nature. 142 116 10.1038/142116a0 1:CAS:528:DyaA1cXkvFOktw%3D%3D
20. O Tetsuya Y Hiroshi K Yoshio 1999 Control of medicine release from solid dispersion composed of the poly (ethylene oxide)-carboxyvinylpolymer interpolymer complex by varying molecular weight of poly (ethylene oxide) J Controlled Release. 58 87 95 10.1016/S0168-3659(98)00145-X (Pubitemid 29371816)
21. LX Liu G Khang JM Rhee HB Lee 2000 Monolithic osmotic tablet system for nifedipine delivery J Controlled Release. 67 309 22 10.1016/S0168-3659(00)00222- 4 1:CAS:528:DC%2BD3cXjsVegtrY%3D (Pubitemid 30303844)
22. SW Larsena J ∅stergaarda, et al. 2007 Diflunisal salts of bupivacaine, lidocaine and morphine Use of the common ion effect for prolonging the release of bupivacaine from mixed salt suspensions in an in vitro dialysis model Eur J Pharm Sci 31 172 9 10.1016/j.ejps.2007.03.005 (Pubitemid 46818977)
23. EX Lu ZQ Jiang QZ Zhang XG Jiang 2003 A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic. suspending and expanding agent J Controlled Release 92 375 82 10.1016/S0168-3659(03)00371-7 1:CAS:528:DC%2BD3sXot1Srsbo%3D (Pubitemid 38366159)